BRAF and cancer: Although sufficient quality RNA and tumor-normal paired WGS can be difficult to obtain for certain types of cancer, we could confidently detect lowly expressed gene fusions such as KIAA1549–BRAF and fusions in samples with low tumor cell percentages (30–40%) (Table S2).